Arvee Laboratories (India) Ltd.

NSEI:ARVEE Stock Report

Market Cap: ₹2.0b

Arvee Laboratories (India) Past Earnings Performance

Past criteria checks 3/6

Arvee Laboratories (India)'s earnings have been declining at an average annual rate of -2.5%, while the Chemicals industry saw earnings growing at 14.6% annually. Revenues have been declining at an average rate of 3.3% per year. Arvee Laboratories (India)'s return on equity is 7.3%, and it has net margins of 6.2%.

Key information

-2.5%

Earnings growth rate

-5.2%

EPS growth rate

Chemicals Industry Growth17.7%
Revenue growth rate-3.3%
Return on equity7.3%
Net Margin6.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Popularity With Investors Under Threat As Stock Sinks 25%

Nov 21
Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Popularity With Investors Under Threat As Stock Sinks 25%

Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today

Aug 08
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today

Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching

Apr 13
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching

Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?

Dec 22
Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?

We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease

Sep 16
We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease

Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price

Aug 13
Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price

Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Apr 19
Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Revenue & Expenses Breakdown

How Arvee Laboratories (India) makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NSEI:ARVEE Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2437023630
30 Jun 2433415400
31 Mar 2430311600
31 Dec 232849450
30 Sep 2336916510
30 Jun 2351935620
31 Mar 2361341620
31 Dec 2269849580
30 Sep 2261545570
30 Jun 2249432570
31 Mar 2240026570
31 Dec 2136922420
30 Sep 2148932430
30 Jun 2147727340
31 Mar 2147427560
31 Dec 2047528240
30 Sep 2036917370
30 Jun 2040721740
31 Mar 2045423280
31 Dec 1947825620
30 Sep 1950127540
30 Jun 1952525550
31 Mar 1954923550
30 Jun 1854914640
31 Mar 1847811620
31 Mar 1734416330
31 Mar 162682260
31 Mar 15130-16190
31 Mar 14118080

Quality Earnings: ARVEE has a high level of non-cash earnings.

Growing Profit Margin: ARVEE's current net profit margins (6.2%) are higher than last year (4.4%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: ARVEE's earnings have declined by 2.5% per year over the past 5 years.

Accelerating Growth: ARVEE's earnings growth over the past year (39.9%) exceeds its 5-year average (-2.5% per year).

Earnings vs Industry: ARVEE earnings growth over the past year (39.9%) exceeded the Chemicals industry 8%.

Return on Equity

High ROE: ARVEE's Return on Equity (7.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 04:18
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arvee Laboratories (India) Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution